Avantor, Inc. Q1 FY26 Results

Summary

Avantor, Inc. reported first quarter 2026 net sales of $1,581.4 million, which remained flat compared to the prior year, though organic sales declined by 4.1%. Net income for the quarter decreased to $43.3 million, resulting in a net income margin of 2.7%, while adjusted EBITDA reached $219.4 million with a 13.9% margin. President and CEO Emmanuel Ligner stated that results exceeded expectations due to improved execution in Bioscience and Medtech Products and stabilization in VWR, expressing encouragement by the positive impact of the "Revival" initiative. The company also reaffirmed its fiscal 2026 financial guidance.

Key Highlights

1. 1

   Avantor reported net sales of $1,581.4 million for the first quarter of 2026, which remained flat compared to the first quarter of 2025.

2. 2

   Net income for the quarter decreased to $43.3 million from $64.5 million in the prior-year period, resulting in a net income margin of 2.7%.

3. 3

   Adjusted EBITDA stood at $219.4 million, achieving an adjusted EBITDA margin of 13.9% for Q1 2026.

4. 4

   Diluted GAAP earnings per share were $0.06, while adjusted diluted earnings per share reached $0.17.

5. 5

   Operating cash flow was $58.7 million, with free cash flow reported at $25.2 million.

6. 6

   Organic net sales declined by 4.1% in Q1 2026, despite a positive foreign currency translation impact of 4.1%.

7. 7

   The company reaffirmed its fiscal 2026 financial guidance, indicating consistent expectations for the year.